ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
iShares MSCI Switzerland ETF

iShares MSCI Switzerland ETF (EWL)

51.17
-0.23
( -0.45% )
Updated: 15:59:41

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
51.17
Bid
-
Ask
-
Volume
253,655
51.10 Day's Range 51.73
41.55 52 Week Range 53.03
Market Cap
Previous Close
51.40
Open
51.38
Last Trade
146
@
51.17
Last Trade Time
15:59:41
Financial Volume
$ 13,015,160
VWAP
51.3105
Average Volume (3m)
313,214
Shares Outstanding
26,625,000
Dividend Yield
-
PE Ratio
7.58
Earnings Per Share (EPS)
6.77
Revenue
31.59M
Net Profit
180.16M

About iShares MSCI Switzerland ETF

The investment seeks to track the investment results of the MSCI Switzerland 25/50 Index. The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts representing securities in its underlying index. The underlying index is a free ... The investment seeks to track the investment results of the MSCI Switzerland 25/50 Index. The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts representing securities in its underlying index. The underlying index is a free float-adjusted market capitalization-weighted index with a capping methodology applied to issuer weights so that no single issuer exceeds 25% of the underlying index weight, and all issuers with a weight above 5% do not cumulatively exceed 50% of the underlying index weight. The fund is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
Headquarters
Lutherville Timonium, Maryland, USA
Founded
-
iShares MSCI Switzerland ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker EWL. The last closing price for iShares MSCI Switzerland... was $51.40. Over the last year, iShares MSCI Switzerland... shares have traded in a share price range of $ 41.55 to $ 53.03.

iShares MSCI Switzerland... currently has 26,625,000 shares outstanding. The market capitalization of iShares MSCI Switzerland... is $1.37 billion. iShares MSCI Switzerland... has a price to earnings ratio (PE ratio) of 7.58.

EWL Latest News

Switzerland ETFs: Safest Play in Europe? - ETF News And Commentary

Europe has rebounded quite well and is now performing remarkably on rising consumer confidence, declining unemployment rates, rising exports, firmer currency, less concerns on debt levels as...

Switzerland ETFs in Focus on China FTA Deal - ETF News And Commentary

Switzerland, unlike many other European economies, has maintained a budget surplus and a credit rating of 'AAA'. The unemployment rate of the nation is also much lower than the...

5 ETFs for Countries with Highest Employment Rates - ETF News And Commentary

Unemployment has been drifting higher for some of the major developed and emerging economies. U.S. and European nations have seen unemployment levels rise dramatically in the recent past. This...

Three European ETFs with Incredible 2012 Gains - ETF News And Commentary

European woes continue to cast a shadow over the world economy. The Euro-zone reported negative growth of 0.10% in the third quarter of fiscal 2012, a small improvement from a contraction of...

Switzerland ETF Investing 101 - ETF News And Commentary

The European economies have floundered because of the financial disaster in several countries in the Eurozone. European woes continue to hamper the world economy with mounting concern for the...

ETFs for the Most Competitive Countries on Earth - ETF News And Commentary

As the world economy becomes more intertwined, competition between various nations is becoming more intense. As a result, a great focus has been on establishing a more business-friendly climate...

ETF Trading Report: Swiss, Health Care ETFs In Focus - ETF News And Commentary

Stocks had trouble staying above water during Wednesday’s session as Jamie Dimon’s testimony and weak retail sales weighed on stocks. Speculation about Greek elections didn’t...

ETF Trading Report: Swiss, Real Estate ETFs In Focus - ETF News And Commentary

Despite more worries from Spain and Europe in general, U.S. equity markets managed to rise broadly in Tuesday trading. The day’s gains largely came from strength in the banking sector as...

For Europe ETFs, It Is Hard To Beat Switzerland - ETF News And Commentary

As the European crisis continues to dominate the headlines, many investors have looked to nations outside the troubled euro zone for their exposure to the region. For good reason too, as a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.10.19580967299851.0751.58550.39528694151.21295863SP
4-0.61-1.1780610274251.7853.0350.39529491951.71903258SP
122.926.051813471548.2553.0347.7331321450.1533175SP
263.1826.6308243727647.98853.0345.0441171448.18248403SP
525.913.032913629345.2753.0341.5550029146.66256941SP
1563.677.7263157894747.553.0636.01595338946.18544836SP
26013.6336.307938199337.5453.0629.5597342144.52661217SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

Discussion

View Full Feed
Hosai Hosai 3 minutes ago
Also on a practical level can't see the EMA loving the Longeveron drug:

"Cell-based therapies like Lomecel-B, which use live mesenchymal stem cells (MSCs), are generally sensitive to temperature fluctuations. To maintain cell viability, they often need to be stored and transported at
AVXL
AugustaFriends AugustaFriends 3 minutes ago
$VVOS explain.. you mean sell or buy now.. explain your post
VVOS
Nihil8 Nihil8 3 minutes ago
U sell lies to morons GFY
CNNA
Golden Cross Golden Cross 3 minutes ago
$CBDW chart showing strong signs of a reversal.
CBDW
jimmirehman jimmirehman 3 minutes ago
CEO is now proven to be untrustworthy. This is going to end bad for all of us $gme kitty farked us
GME
cjstocksup cjstocksup 3 minutes ago
https://x.com/elonmusk/status/1836274063259718017?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1836274063259718017%7Ctwgr%5E909fe922cc4aa4cf9693913defef703a792bf555%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Fresistthemainstream.com%2Felon-musk-burns-abc-with-four-words-after-crushing-x-video-goe
BIOCHEMUP BIOCHEMUP 3 minutes ago
Check rapi
AAPJ
SkyLimit2022 SkyLimit2022 4 minutes ago
Investor082,

https://youtu.be/rmPRHJd3uHI
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175104521
NWBO
Doc logic Doc logic 4 minutes ago
manibiotech,

I think flipper44 was on to something with the change in primary completion date for the combo trial. Perhaps Merck senses the need to be able to announce major news before BMY might receive a favorable decision in December. If BMY gets turned down then they look even s
BMY
Golden Cross Golden Cross 4 minutes ago
$CBDW chart showing strong signs of a reversal.
CBDW
Nighthawk_1 Nighthawk_1 4 minutes ago
It's even quite possible, in my opinion, that with all the creditors that are owed, that MULN may be looking at the R/S. But, there is a possibility MULN could go into bankruptcy. Maybe not a chpt 7, but possible chpt 11 or 13. Just my thoughts and views. Glad out yesterday. Of course, nothing will
MULN
BIOCHEMUP BIOCHEMUP 4 minutes ago
Oh boy with PPS back in a range like before EM, seems like EM not having so much impact on our PPS. Should have never been on EM but I’m confident mgmt has a plan for us!
RSPI
Acme Investments Acme Investments 4 minutes ago
Win,win is the goal!! Much easier to get your salary from a good share price!! I'm going to follow your lead!! If I see your dedication I will hold to see what your vision is!!
BCAP
manibiotech manibiotech 4 minutes ago
I hope they already have some negotiated contingent deal that they can announce with approval .
They have been promising flurry of PRs for years now
NWBO
Humbert Humbert 4 minutes ago
Yeah, I also think a dividend will be established here, at some point.

Things will pick up again shortly.
BNCM
Golden Cross Golden Cross 4 minutes ago
$CBDW and Adnexus partnership news from yesterday, if anyone missed it!
https://finance.yahoo.com/news/adnexus-biotechnologies-partners-1606-corp-120000325.html
CBDW
Double DD Double DD 4 minutes ago
Pretty sure that's about 900g in 2 days up in 7s and 8s!! Churn here couple more days!! Igpk
IGPK
m$teamworkotc m$teamworkotc 5 minutes ago
https://x.com/num1willis/status/1833671859277090944
MULN
postal72 postal72 5 minutes ago
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001814215/5a421d89-caa0-467b-ab28-e120fcbb0d57.pdf
BURU
blackhawks blackhawks 5 minutes ago
Spend less time rolling around on the floor and more time trying to back up your bullshit.

Takes time to fix what Trump broke through his stupidity and negligence.

Move your lips, if it helps your poor reading comprehension, and read again. All of it is accurate and ver
ShawnP123 ShawnP123 5 minutes ago
That is a more realistic assessment. But I don't see this stock hitting above 140-145. One of the major problems with today's stock market is as follows:

Years ago we had a number of neutral days with little movement. Today it is totally unacceptable. So traders will take any excuse t
NVDA
Pharma Sleuth Pharma Sleuth 5 minutes ago
Here is a question. If you were looking to buy a public company with billions in upcoming catalysts. A $5b drug pending approval now and soon. Launching a billion now to double current marketed drugs.

What is one of the first things you would do?

Just something I've be
ELTP
lvhd lvhd 5 minutes ago
In 20.80
INTC
Golden Cross Golden Cross 6 minutes ago
$CBDW and Adnexus partnership news from yesterday, if anyone missed it!
https://finance.yahoo.com/news/adnexus-biotechnologies-partners-1606-corp-120000325.html
CBDW

Your Recent History

Delayed Upgrade Clock